Invention Grant
- Patent Title: Intradermal combination vaccine against mycoplasma and porcine circovirus
-
Application No.: US16955015Application Date: 2018-12-19
-
Publication No.: US11744883B2Publication Date: 2023-09-05
- Inventor: Jordi Montane Giralt , Ester Puigvert Molas , Alexandra Moros Sanz , Marta Sitjà Arnau
- Applicant: HIPRA SCIENTIFIC, S.L.U.
- Applicant Address: ES Girona
- Assignee: HIPRA SCIENTIFIC, S.L.U.
- Current Assignee: HIPRA SCIENTIFIC, S.L.U.
- Current Assignee Address: ES Amer
- Agency: Saul Ewing LLP
- Agent Kathryn Doyle
- Priority: EP 382893 2017.12.22
- International Application: PCT/EP2018/085844 2018.12.19
- International Announcement: WO2019/121916A 2019.06.27
- Date entered country: 2020-06-17
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/12 ; A61P31/20 ; A61K9/00 ; A61K39/39 ; A61K39/00
Abstract:
The present invention provides a combination vaccine comprising one or more antigens of Mycoplasmahyopneumoniae, one or more antigens of Porcine circovirus, and pharmaceutically acceptable excipients and/or carriers, for use in the prevention and/or treatment of porcine enzootic pneumonia and/or Porcine Circovirus-Associated Diseases (PCVAD) by administration of the vaccine into the dermis of livestock, wherein the one or more antigens of porcine circovirus comprises the PCV2 ORF2 protein in an amount from 0.1 μg/dose to 10 μg/dose.
Public/Granted literature
- US20200376106A1 INTRADERMAL COMBINATION VACCINE AGAINST MYCOPLASMA AND PORCINE CIRCOVIRUS Public/Granted day:2020-12-03
Information query
